Top 4 Small-Cap Stocks In The Diagnostic Substances Industry With The Highest ROA

Below are the top small-cap diagnostic substances stocks on the NYSE and the NASDAQ in terms of return on assets. The trailing-twelve-month return on assets at AMAG Pharmaceuticals, Inc. AMAG is 19.90 percent. AMAG Pharmaceuticals' revenue for the same period is $124.40 million. The trailing-twelve-month return on assets at Meridian Bioscience, Inc. VIVO is 19.70 percent. Meridian Bioscience's PEG ratio is 1.33. The trailing-twelve-month return on assets at SurModics, Inc. SRDX is 12.40 percent. SurModics' EPS for the same period is $0.89. The trailing-twelve-month return on assets at Neogen Corporation NEOG is 8.80 percent. Neogen's profit margin for the same period is 11.70 percent.